Dense breasts and inflammation further linked to breast cancer risk
A new study by University of Wisconsin Carbone Cancer Center researchers has found that dense breasts and inflammation are associated with poor prognosis in breast-cancer patients, and suggests that an FDA-approved drug may improve prognosis for those patients with dense breasts.
UW Carbone study: Caregiver spouses of cancer patients suffer untreated depression
A new study from the University of Wisconsin Carbone Cancer Center highlights a troubling disparity in cancer care: the depressed spouses of cancer patients are 33 percent less likely to receive adequate treatment for depression than are patients whose spouses don’t have cancer. In rural areas, it’s even worse: Couples who live in rural areas are 72 percent less likely to receive recommended care for depression (including medication and talk therapy) than the depressed spouses of those without cancer.
The Ride funds $352,000 in cancer research at Carbone Cancer Center
Research efforts at the University of Wisconsin Carbone Cancer Center received a $352,000 boost this weekend when The Ride announced the winners of 14 scholarships during the Badger hockey game Saturday night.
Study provides a potential therapeutic strategy for aggressive lymphoma
Researchers at the University of Wisconsin School of Medicine and Public Health have found a molecular regulator that controls cell life in diffuse large B cell lymphoma, the most common, aggressive form of lymphoma.
New study to help women make better breast-cancer surgery decisions
Women face big decisions soon after being hit with a cancer diagnosis, including whether to have a breast-conserving lumpectomy or mastectomy.
Radiology training program earns national recognition
The Radiology training program at the University of Wisconsin School of Medicine and Public Health was recently named the best of its kind in the country by AuntMinnie.com, an online resource of information, news and education about the field of medical imaging.
Myeloma vaccine research earns $600,000 Leukemia and Lymphoma Society grant
UW Carbone Cancer Center hematologist and myeloma researcher Fotis Asimakopoulos, MD, PhD, was awarded a Leukemia and Lymphoma Society grant to identify patients mostly likely to benefit from a personalized cancer vaccine.
Jim Cleary named a visionary in hospice and palliative medicine
Jim Cleary, MD, founding medical director of the Palliative Medicine Service at UW Health, was named one of the 30 most influential leaders in hospice and palliative medicine, the medical specialty focused on relieving suffering and improving quality of life for people with serious illnesses.
UW study uses ‘bio-panning’ to find human antibodies for brain cancer stem cells
Using a method described as similar to panning for gold, Carbone Cancer Center scientists discovered human antibodies for the cancer stem cells of glioblastoma, one of the most difficult brain cancers to treat.
UW Carbone oncologist leads effort to educate about cancer risk of alcohol
Drinking alcohol increases the risk of several types of cancer, something many of Dr. Noelle LoConte’s patients are surprised to learn.
Alan Rapraeger awarded $1.9 million grant to study myeloma cell signaling
Alan Rapraeger, MD, professor of human oncology at the University of Wisconsin School of Medicine and Public Health, has been awarded a five-year, $1.9 million R01 grant from the National Cancer Institute to investigate signaling mechanisms that drive myeloma cell proliferation, survival and invasion.
New study shows how cells can be led down non-cancer path
As cells with a propensity for cancer break down food for energy, they reach a fork in the road: They can either continue energy production as healthy cells, or shift to the energy production profile of cancer cells.